The Potential Use of Nanoparticles for Noggin siRNA Delivery to Accelerate Bone Formation in Distraction Osteogenesis


Authors: Bassit ACF, Moffatt P, Gaumond MH, Hamdy R

Journal: Journal of Nanomedicine and Nanotechnology

DOI: 10.4172/2157-7439.1000257

Publication - Abstract

January 01, 2015

Abstract:

In bone research and orthopedics, RNA-interference (RNAi) and nanotechnology can be applied to a vast array of conditions where bone formation needs to be enhanced, providing new options to treat old problems, from osteoporosis and bone tumors to nonunion and critical size defects. The need for new therapeutic tools to improve bone regeneration is evident, mainly in more complex orthopedic surgical procedures. Distraction Osteogenesis (DO) is a unique surgical technique that stimulates bone formation, most frequently used to promote limb lengthening through slow and progressive distraction after osteotomy. The great challenge is to reduce the consolidation phase and prevent the complications related to the maintenance of the external fixator for a long period. Bone Morphogenetic Proteins (BMPs) have been used as potent osteoinductive growth factors, but we considered manipulating the BMP-antagonist NOGGIN through RNA silencing to increase endogenous BMPs levels, as an option for the controversial use of exogenous BMPs. For RNAi-based therapies, the greatest challenge over the past 16 years has been to achieve safe, effective and specific delivery to the target tissue. In-vivostudies employed a variety of delivery methods aiming for the ultimate clinical translational application for RNAi technology, but RNAi drugs are still undergoing clinical trials for approval by the US Food and Drug Administration (FDA). This review considers the application of nanotechnology to potentially address the difficulties of delivering silencing RNAs in vivo and in clinical applications, and presents preliminary studies about downregulation of the BMP-antagonist NOGGIN through RNAi in rat bone cells and delivery of siRNA sequences to bone tissue by nanoparticles.

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Blog Posts
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies

Dejanovic, B., Huntley, M. A., De Mazière, A., Meilandt, W. J., Wu, T., Srinivasan, K., . . . Sheng, M.

Synapse loss and Tau pathology are hallmarks of Alzheimer’s disease (AD) and other tauopathies, but how Tau pathology causes synapse loss is unclear. We used unbiased proteomic analysis of postsynaptic densities (PSDs) in Tau-P301S transgenic mice to identify Tau-dependent ...
Read More


Publication - Summary

Liposomes are an established delivery system for therapeutics, but liposome production methods have suffered from issues relating to quality and scalability that must be overcome before liposomes can be widely employed in clinical applications.

Read More


Stay Informed

Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.

MENU
X